Insider Trading Alert - MRD, GEVO And CRM Traded By Insiders

Yesterday, July 12, 2016, 36 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $9.28 to $1,874,700.00.

Highlighted Stocks Traded by Insiders:

Memorial Resource Development (MRD) - FREE Research Report

Fenley Tyler Joseph, who is Shareholder at Memorial Resource Development, sold 25,000 shares at $16.42 on July 12, 2016. Following this transaction, the Shareholder owned 87,661 shares meaning that the stake was reduced by 22.19% with the 25,000-share transaction.

The shares most recently traded at $16.12, down $0.30, or 1.84% since the insider transaction. Historical insider transactions for Memorial Resource Development go as follows:

  • 4-Week # shares sold: 30,000
  • 12-Week # shares sold: 80,000
  • 24-Week # shares bought: 8,127
  • 24-Week # shares sold: 380,000

The average volume for Memorial Resource Development has been 3.3 million shares per day over the past 30 days. Memorial Resource Development has a market cap of $3.4 billion and is part of the basic materials sector and energy industry. Shares are up 2.66% year-to-date as of the close of trading on Tuesday.

Memorial Resource Development Corp., an independent natural gas and oil company, engages in the acquisition, exploitation, and development of natural gas, natural gas liquids, and oil properties primarily in North Louisiana. The company has a P/E ratio of 57.3. Currently, there are 7 analysts who rate Memorial Resource Development a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MRD - FREE

TheStreet Quant Ratings rates Memorial Resource Development as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, generally high debt management risk, generally disappointing historical performance in the stock itself, weak operating cash flow and poor profit margins. Get the full Memorial Resource Development Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Gevo (GEVO) - FREE Research Report

Gruber Patrick R., who is Chief Executive Officer at Gevo, sold 108 shares at $0.58 on July 12, 2016. Following this transaction, the Chief Executive Officer owned 41,259 shares meaning that the stake was reduced by 0.26% with the 108-share transaction.

Ryan Christopher Michael, who is President and COO at Gevo, sold 121 shares at $0.58 on July 12, 2016. Following this transaction, the President and COO owned 37,725 shares meaning that the stake was reduced by 0.32% with the 121-share transaction.

Roda Gregory, who is Chief Commercial Officer at Gevo, sold 16 shares at $0.58 on July 12, 2016. Following this transaction, the Chief Commercial Officer owned 8,541 shares meaning that the stake was reduced by 0.19% with the 16-share transaction.

The shares most recently traded at $0.56, down $0.02, or 3.57% since the insider transaction. Historical insider transactions for Gevo go as follows:

  • 4-Week # shares bought: 181,484
  • 4-Week # shares sold: 118
  • 12-Week # shares bought: 181,484
  • 12-Week # shares sold: 816
  • 24-Week # shares bought: 181,484
  • 24-Week # shares sold: 5,553

The average volume for Gevo has been 9.8 million shares per day over the past 30 days. Gevo has a market cap of $20.8 million and is part of the basic materials sector and chemicals industry. Shares are down 8.06% year-to-date as of the close of trading on Tuesday.

Gevo, Inc., a renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. It operates in two segments, Gevo, Inc. and Gevo Development/Agri-Energy. Currently, there is 1 analyst who rates Gevo a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GEVO - FREE

TheStreet Quant Ratings rates Gevo as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself and generally high debt management risk. Get the full Gevo Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Salesforce.com (CRM) - FREE Research Report

Roos John Victor, who is Director at Salesforce.com, sold 155 shares at $81.94 on July 12, 2016. Following this transaction, the Director owned 17,540 shares meaning that the stake was reduced by 0.88% with the 155-share transaction.

The shares most recently traded at $81.97, up $0.03, or 0.04% since the insider transaction. Historical insider transactions for Salesforce.com go as follows:

  • 4-Week # shares sold: 15,502
  • 12-Week # shares sold: 106,411
  • 24-Week # shares sold: 857,629

The average volume for Salesforce.com has been 3.7 million shares per day over the past 30 days. Salesforce.com has a market cap of $54.8 billion and is part of the technology sector and computer software & services industry. Shares are up 4.5% year-to-date as of the close of trading on Tuesday.

salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. Currently, there are 27 analysts who rate Salesforce.com a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRM - FREE

TheStreet Quant Ratings rates Salesforce.com as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Salesforce.com Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

AMD Shares Surge After Solid Q1, Robust Outlook Defies Chip Sector Gloom

AMD Shares Surge After Solid Q1, Robust Outlook Defies Chip Sector Gloom

Facebook Stock Set for Biggest Gain in Two Years After Q1 Earnings Top Forecasts

Facebook Stock Set for Biggest Gain in Two Years After Q1 Earnings Top Forecasts

Facebook, Amazon, Microsoft and Ford - 5 Things You Must Know

Facebook, Amazon, Microsoft and Ford - 5 Things You Must Know

Global Stocks Mixed, U.S. Futures Soften as Earnings, Oil, Rates Cloud Sentiment

Global Stocks Mixed, U.S. Futures Soften as Earnings, Oil, Rates Cloud Sentiment

European Automakers Gain on Reports China Mulling Auto Tariff Reduction

European Automakers Gain on Reports China Mulling Auto Tariff Reduction